OR WAIT null SECS
January 09, 2024
The potential for superpotent drug initiated the voluntary recall.
January 03, 2024
European bio/pharma companies have no choice but to invest and adapt to the evolving industry needs.
Novel molecular glues are transforming targeted protein degradation.
UK scientists are once again able to participate in the Horizon European research programme thanks to a deal struck in 2023.
January 02, 2024
The EHDS aims to increase access to health data, but how will it impact pharma?
Clarivate has released its 2024 Drugs to Watch report, highlighting 13 therapies with great potential.
December 29, 2023
Clinician-Scientists are vital innovation spark plugs, accounting for 40% of Nobel awards in Physiology or Medicine, and two thirds of Big Pharma CSOs.
December 27, 2023
The midterm report of the European Medicines Agencies Network Strategy finds that the network has strengthened and is on track to achieve its objectives.
December 26, 2023
WHO provides a look at the world’s health as the agency turns 75.
December 21, 2023
The final guidance document provides recommendations for designing a new registry or using an existing registry to support decisions regarding safety and effectiveness of a drug.